Аналитика и торговые сигналы Биржевая аналитика с фондовых площадок и торговые сигналы практикующих трейдеров.

Ответить
28.08.2014, 15:46
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

Доллар Ежедневный обзор рынка от GT Capital

В этой ветке каждое утро компания GT Capital Group будет публиковать свой обзор рынка США.

Компания GT Capital Group образована группой профессиональных трейдеров.
Цель
Наша миссия принести в сообщество русских трейдеров профессионализм и высокое качество услуг. Мы внимательно ознакомились с проблемами, существующими в России в этой сфере и изначально приняли меры по организации бизнеса, опережающие существующие общепринятые системы на несколько лет. Этот подход – на опережение – отражен, как и в оказании сервиса по торговле ценными бумагами, так и в профессиональном обучении на основе американских стандартов.
Описание
Дейтрейдинг на американских фондовых биржах: NYSE, NASDAQ, AMEX. Проп-торговля, обучение, аналитика и дополнительные сервисы для трейдеров. Депозит - от $500.

С наилучшими пожеланиями,
Команда GT Capital Group
http://gtstocks.com
info@gtstocks.com




Американские индексы падают перед открытием торгов


Ближайший уровень поддержки по SPY – 199.45 уровень сопротивления – 200.00

Изображение

HUM продажа ниже 127

BITA продажа ниже 88

ATHM продажа ниже 50

QIHU продажа ниже 88

GMCR продажа ниже 134

Gapping up/down: SIG +3% after earnings, DGLY +14% after new order announcement, RPRX +12% after study results, FEYE +2% after initiation w/Buy; GOMO-22%, GES -8.3% and ANF -6% after earnings, GTAT -2% after dg

Gapping up
In reaction to strong earnings/guidance: EDAP +4.2%, SIG +2.7%, VNET +2%, DATE +1.8%, LCI +1.7%, WDAY +1.3%.

Select metals/mining stocks trading higher: GFI +2.2%, SLV +1.7%, HL +1.6%, GG +1.4%, IAG +1.3%, AEM +1.3%, SLW +1.3%, ABX +1.3%, AUY +1.3%, GOLD +0.8%.

Other news: CREG +24.5% (Chairman Guohua Ku has entered into a share purchase agreement to purchase ~13.83 mln shares at $1.37/share), DGLY +13.8% (receives order from State Police Of Michigan valued at more than $1.1 mln), ETRM +13.1% (announces three year diabetes, hypertension and weight loss data from the Maestro RC system DM2 ENABLE study), RPRX +12.6% (achieves superiority in top line analysis for both co-primary endpoints and various secondary endpoints versus marketed topical gel in first of two identical studies in the treatment of secondary hypogonadism), TKMR +9.4% (story suggesting it is a takeover candidate; lists GlaxoSmithKline (GSK) and Shire (SHPG) as interested parties), SYN +8.1% (Co and FUJIFILM Diosynth Biotechnologies UK announce significant improvement in API manufacturing of SYN-004 for the prevention of C. difficile), SCLN +7.5% (and BTG announce that DC Bead has been approved by China FDA ), MRCY +2% (receives $27 mln order for airborne sensor processing application; follows $39 mln missile defense radar subsystems order received last quarter ), WOOF +1.7% (announces new $1.4 billion credit facility and share repurchase authorization of up to $400 million), AVIV +1.7% (to join the S&P SmallCap 600), CNC +1.5% (to join the S&P MidCap 400)

Analyst comments: FEYE +1.7% (initiated with a Buy at Stifel), CRH +1.5% (upgraded to Outperform from Underperform at Credit Suisse), PANW +0.9% (resumed with a Buy at Stifel), FHN +0.8% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), GOLD +0.8% (upgraded to Neutral from Underweight at HSBC Securities), SMTC +0.8% (resumed with a Buy at Goldman)

Gapping down
In reaction to disappointing earnings/guidance: GOMO -21.8%, WSM -10.5%, TLYS -9.6%, FRO -8.9%, GES -8.3%, GCO -6.5%, ANF -6.1%, GMAN -5.8%, HSOL -5.5%, VE -1.7%, VMEM -1.2%,.

M&A news: TEF -0.8% (raises bid offer for Vivendi's (VIVHY) GVT unit).

Select EU financial related names showing weakness: DB -2.1%, SAN -1.7%, UBS -0.8%

Select metals/mining stocks trading lower after Austrian steelmaker Voestalpine AG sees drop in iron ore prices due to over supply: RIO -3.6%, MT -2.1%, BHP -1.9%, CLF -1.9%.

Select Biotech related names showing early weakness: ISNS -4.2%, FOLD -3.1%, MACK -1.8%, ARWR -1.8%, ACHN -1.5%, ARIA -1.1%

Other news: ROX -7.3% ((filed for $30 mln mixed securities shelf offering), TIF -0.5% (filed mixed securities shelf offering),), RSH -3.7% (pulling back from yesterday's 20% gain), FOLD -3.1% (still checking), RSX -3.1% (new reports of Russian invasion into Ukraine), AEO -2.3% (in sympathy with ANF), RH -2% (following WSM results), YNDX -1.8% (Russian exposure).

Analyst comments: GTAT -2.2% (downgraded to Underperform from Mkt Perform at Raymond James), NOK -2% (removed from Europe 1 List at BofA/Merrill ), HTZ(e) -1.2% (heaing estimates cut at MS), V -0.8% (downgraded to Mkt Perform from Outperform at Raymond James)

Оригинал статьи: gtstocks.com/analytics-28-08-2014.html
29.08.2014, 13:50
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY гэпает вверх в начале дня

Ближайший уровень поддержки по SPY – 200.50 уровень сопротивления – 200.85



EMES покупка выше 141

SLCA покупка выше 71.50

MNK покупка выше 80.50

BOBE смотрим на откат вверх

Gapping up/down:
SPLK +7% and RALY +6% after eranings, CRTO +21% on M&A spec, TSLA +2% on deal with CHU, SSYS +1.5% after Buy initiation; ZOES -1% on earnings, GOMO -1% after dg at CS

Gapping up
In reaction to strong earnings/guidance: UEPS +17.9%, VEEV +12.2%, SPLK +6.7%, RALY +6.4%, ANFI +5.4%, AVGO +5.3%, PSUN +4.3%, BONA +3.9%, FRED +2.9%, CO +2.3%, OVTI +2.3%.

M&A news: CRTO +20.7% (may be attributed to Publicis (PUBGY) speculation), AZN +2.2% (reports that Pfizer (PFE) and AZN may have resumed merger talks),.

Select Biotech related names showing strength: FOLD +5.2%, AEZS +3.6%, KERX +0.7%, ACHN +0.5%.

Other news: DGLY +7.1% (continue momentum higher), BCRX +4.1% (receives additional NIAID funding to conduct a non-human primate study of BCX4430 in Ebola virus disease), RSH +3.5% (cont strength), CHU +3.4% (agreement with Tesla for charging stations), NXPI +3% (Apple and NXP Semi (NXPI) working on payment system technology for iPhone, according to reports), KNDI +2.1% (China considering new tax on gasoline to help electric car market, according to reports), TSLA +1.7% (has agreed to deal with China Unicom (CHU) for charging stations, according to reports)

Analyst comments: SSYS +1.5% (initiated with a Buy at Stifel), CRH +1.1% (upgraded to Buy from Neutral at Goldman)

Gapping down
In reaction to disappointing earnings/guidance: ZOES -1.3%, BIG -0.5%

Select Russia related names showing weakness (Russian stocks downgraded at Morgan Stanley): MBT -3.8% (also dg'd at DB, see below), RSX -1.3%, VIP -1%, YNDX -0.9%.

Other news: ISNS -6.6% (may be related to large shareholder selling shares), FRO -2.2% (cont weakness), NOAH -1.2% (still checking), MCHP -0.6% (co confirmed it is in preliminary discussions with CSR plc).

Analyst comments: MBT -3.8% (downgraded to Hold from Buy at Deutsche Bank), GOMO -1.2% (downgraded to Neutral from Outperform at Credit Suisse).
02.09.2014, 14:28
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY открывает неделю гэпом вверх

Ближайший уровень поддержки по SPY – 200.80 уровень сопротивления – 201.20



Gapping up/down: DGLY +15% after guidance, CPWR +15%, FLWS 13%, and TMUS+3% on M&A news, TSLA +3% on upgrade; CONN -25% after earnings, metals and miners trading lower, OSIS -3% after dg

Gapping up
In reaction to strong earnings/guidance: DGLY +15.5%, FORM +2.4%, KFX +1.1%, (also announces acquisition of Softpro GmbH) ZNH +1%, GZT +0.7%.

M&A news: CPWR +15% (WSJ reporting that company is in sale discussions), FLWS +12.6% (signs definitive agreement to acquire Harry & David Holdings for $142.5 mln in cash), TMUS +2.8% (Illiad (ILIAY) in discussions with buyout firms regarding TMUS bid, according to reports), DG +1.7% (to raise bid for FDO for $80/share), TSL +1.4% (acquires Majority Stake in Yunnan Metallurgical New Energy), ARCP +0.8% (confirms Cole Corporate Income Trust entered into merger agreement relating to the sale of CCIT to Select Income REIT (SIR)), FDO +0.6% (Dollar General (DG) confirms enhanced proposal to acquire Family Dollar).

Select pharma/biotech related names showing strength: ELOS +10.5%, ZGNX +5.9% (reports that Zohydro ER demonstrates sustained 12-hour pain relief), ARNA +3.9%, NVS +3.5% (new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial, early results of upcoming presentations).

Other news: HGSH +43.2% (signed its second shanty area rebuilding project agreement with a budgeted investment over $750 mln), ASTI +21.2% (announces new common stock investment of $8.0 mln led by largest shareholder), SYNA +4.7% (positive Barron's mention), USG +3.5% (positive Barron's mention), ISNS +2.4% (in sympathy with DGLY), NXPI +2.2% (reports that Apple (AAPL) may partner with Visa (envy) and Mastercard (MA) for payment applications), DTV +1.9% (still checking), OWW +1.8% (reaches an agreement with American Airlines (AAL) to continue to offer American Airlines and US Airways (LCC) flights on all of its sites), BLDP +1.8% (appoints Randy MacEwen as President and Chief Executive Officer, effective October 6, 2014), PBA +1.2% (to acquire the Vantage pipeline system and Mistral Midstream's interest in the Saskatchewan Ethane Extraction Plant), NBG +0.9% (still checking), YHOO +0.8% (Alibaba.com to begin roadshow next week, according to reports).

Analyst comments: SPLS +4.9% (upgraded to Outperform from Neutral at Credit Suisse), SD +3.4% (upgraded to Buy at Stifel), CENX +3% (upgraded to Overweight from Equal-Weight at Morgan Stanley), GRPN +2.9% (upgraded to Sector Perform at RBC Capital Mkts), STO +2.9% (upgraded to Buy from Hold at Deutsche Bank), TSLA +2.9% (upgraded to Buy from Hold at Stifel), DSKY +2.6% (initiated with a Overweight at Piper Jaffray), ACHN +2.6% (tgt raised to $15 from $11 at UBS), TS +2.4% (upgraded to Neutral from Sell), RCAP +1.9% (upgraded to Buy from Neutral at Citigroup), ZU +1.5% (upgraded to Buy from Fair Value at CRT Capital), ANET +1.3% (initiated with a Buy at Sun Trust Rbsn Humphrey), COG +1% (upgraded to Buy at Stifel), AAPL +0.8% (target raised to $120 from $105 at Piper Jaffray)

Gapping down
In reaction to disappointing earnings/guidance: CONN -25.5%, VIVO -0.6%.

Select pharma/biotechl related names showing weakness: AMPE -5.1% (announces update on the phase III, multicenter, double-blind STEP study of Ampion for osteoarthritis of the knee), GSK -1.6%, AZN -1.1%.

Select metals/mining stocks trading lower: GFI -2.5%, PAAS -2.4%, NEM -2.1%, GG -2%, GDX -1.8%, SLV -1.7%, GOLD -1.7%, GLD -1.6%, SLW -1.4%,.

Other news: EXEL -52.4% (announces results from the COMET-1 Phase 3 pivotal trial of Cabozantinib in men with metastatic castration-resistant prostate cancer), RIBT -17.4% (disclosed its Irgovel plant experienced a structural breakdown; co withdraws prior guidance), TWGP -11.9% (received a letter from the SEC stating that the SEC is conducting an investigation and attaching a subpoena for various documents), PT -2.7% (still checking), LXRX -1.3% (files for $150 mln mixed securities shelf offering), PXLW -1.2% (files $50 mln common stock shelf offering), HSBC -0.9% (stake sold by Fund Manager Neil Woodford, according to reports), CREE -0.7% (LED demand fell in Q3 QoQ, according to reports (not stock specific)).

Analyst comments: OSIS -3.1% (downgraded to Perform from Outperform at Oppenheimer), FNSR -2.5% (downgraded to Hold from Buy at Jefferies), EMES -1.7% (downgraded to Neutral at Robert W. Baird on valuation), FCX -0.5% (downgraded to Equal-Weight from Overweight).

Оригинал статьи: gtstocks.com/analytics-02-09-2014.html
04.09.2014, 14:18
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
Фьючерсы на индексы растут

Ближайший уровень поддержки по SPY – 200.60 уровень сопротивления – 201.20



MNK продолжает расти выше на премаркете

GD покупка выше 125

RPRX покупка от 18

Gapping up/down: ITI +11% and PVH +8% after earnings, BOLT +36% on merger with TDY, MITK +69% on litigation settlement; CIEN -10%, SCVL -9% and JOY -2% after earnings, GPRO -3.7% after dg

Gapping up
In reaction to strong earnings/guidance/SSS: ITI +11.2%, MEI +10.9%, MAGS +9.9%, PVH +8.4%, BV +5.6%, DDC +4.9%, ABM +3.3%, PAY +2.5%, HRB +2%, COST +1.4%, MBLY +1%

M&A news: BOLT +36.6% (to be acquired by Teledyne (TDY) for $22 per share in cash), BWP +2.7% (to acquire Evangeline ethylene pipeline system for $295 mln in cash), SYNL +1.1% (announces sale of Ram-Fab in Crossett, Arkansas to a subsidiary of Primoris Services (PRIM)).

Other news: MITK +68.8% (announced settlement of pending litigation with USAA), SGOC +16.2% (seeing continued strength following yesterday's 50% move higher), TIBX +7.6% (announced a review of strategic alternatives), HMSY +5.3% (modestly rebounding in premkt trade), MHGC +5.1% (announced its special transaction committee has directed Morgan Stanley to reach out to possible counterparties regarding their interest in potential transactions), TASR +3.8% (announces multiple orders of its TASER brand next generation Smart Weapons, aslo positive Mad Money mention), ISNS +3.7% (pulling back following recent gains), NLNK +2.7% (FDA gives NewLink Genetics approval to proceed to phase 1 clinical studies of their ebola vaccine), MPET +2.5% (announces drilling operations on the Horse Hill-1 well commenced on Sep 3, 2014), ALLT +2.2% (announces follow-on order with a Tier-1 global telecommunications group), ECR +2.1% (announced the commencement of production at two of the Co's pad locations consisting of a total of 7 Utica Shale wells; co also reaffirmed its production guidance for Q3), PLUG +1.3% (announces Chris Hutter has been appointed CFO), CELG +0.9% (reported Phase III FIRST trial of REVLIMID Plus Dexamethasone)

Analyst comments: OI +2.2% (initiated with an Outperform at BMO Capital Mkts), DHI +2% (upgraded to Buy from Neutral at UBS), CERN +1.4% (resumed with a Overweight at JP Morgan), HIMX +1.3% (tgt raise at Brean Cap'l), IACI +1.2% (upgraded to Overweight from Equal Weight at Barclays), LPX +1.1% (initiated with an Outperform at BMO Capital Mkts), INFI +1.1% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities), FL +0.6% (initiated with a Buy at Jefferies), COP +0.6% (target raised to $95), PKG +0.5% (initiated with an Outperform at BMO Capital Mkts)

Gapping down
In reaction to disappointing earnings/guidance: MTRX -15.9%, CIEN -10%, SCVL -8.7%, AVAV -6.4%, JOY -2.3%, UTIW -1%

Other news: KMDA -19.3% (eports final results from Phase 2/3 clinical trial of inhaled Alpha-1 Antitrypsin to treat Alpha-1 Antitrypsin deficiency), GNE -8.8% (stated it is considering alternative ways forward for oil shale pilot project in Israel following the Jerusalem District Committee for Planning and Building vote to decline to issue a permit to build and operate an oil shale pilot drilling project), SMLP -4.9% (announced public offering of 4 mln common units by selling unitholders), MEMP -4.8% (announced public offering of 13 mln common units), AI -3.5% (announced offering of 2.75 mln shares of common stock), YUM -3.2% (disclosed significant, negative impact to sales at both KFC and Pizza Hut in China; sees Q3 same store sales -13%), NRF -2.6% (announced public offering of 45 mln shares with a forward component), GRUB -1.4% (prices follow-on public offering of 10,468,198 shares of common stock offered by the co and certain stockholders at $40.25 per share), DEPO -0.6% (announces pricing of upsized $300 mln convertible Senior Notes due 2021)

Analyst comments: TNGO -4.1% (downgraded to Equal Weight from Overweight at Barclays), GPRO -3.7% (downgraded to Neutral from Overweight at JP Morgan), DDD -2.5% (downgraded to Sector Perform from Outperform at Pacific Crest), INFA -1% (downgraded to Equal Weight from Overweight at Barclays), LVS -0.5% (downgraded to Hold from Buy at Argus)

Оригинал статьи: gtstocks.com/analytics-04-09-2014.html
05.09.2014, 14:49
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY упал на премаркете

Ближайший уровень поддержки по SPY – 199.50 уровень сопротивления – 200.30



COST покупка при ужержании 125

EMES покупка выше 125

EGN смотрим на разворот

Gapping up/down: BLOX +13% and AMBA +9% after earnings, PRAN +28% after orphan designation status, CIEN +2% after upgrade; GPX -6% and FNSR -5% after earnings/SSS, KORS -5% after offering

Gapping up
In reaction to strong earnings/guidance: BLOX +13.4%, AMBA +9.3%, LOCO +2.9%, VRNT +2.6%.

Other news: PRAN +27.6% (received orphan designation status for its product for the treatment of Huntington's disease), HART +13.7% (received orphan designation status for its inBreath airway transplant system to restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection), NSPH +10.8% (has engaged Jefferies LLC as its financial advisor to assist it in the development and evaluation of a full range of potential strategic alternatives for the Company), TASR +6% (higher following announcement that the NYPD will begin a pilot program of equipping officers with body cameras), OMED +4.1% (FDA removes partial clinical hold on OncoMed's ipafricept), ICLD +2.8% (announces multi-site deployment of security and threat prevention solutions and services for a large global consulting firm), MOBI +2.6% (announces repurchase of 16 mln shares from Sequoia Capital ), GPRO +1.7% (up in sympathy following supplier AMBA earnings), DGLY +1.5% (cont usual volatility pre-mkt), JOY +1% (positive Barron's mention), SD +0.8% ( announces $200 mln share repurchase program)

Analyst comments: IPCI +3.7% (upgraded to Buy at Maxim Group), VRTX +2.3% (upgraded to Buy from Neutral at Goldman), CIEN +1.8% (upgraded to Buy from Neutral at Goldman), ICPT +1.8% (initiated with an Outperform at Cowen), MTRX +1.7% (upgraded to Overweight from Equal Weight at First Analysis Sec), SNDK +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), BLUE +1.4% (initiated with a Buy at Sun Trust Rbsn Humphrey), INSM +1.4% (initiated with an Outperform at Cowen), MBLY +1.4% (target raised to $52 at RBC Capital Mkts), IL +1.1% (upgraded to Buy at Stifel ), ING +1% (upgraded to Overweight from Equal Weight at Barclays), BEAV +1% (upgraded to Buy from Hold at Deutsche Bank), BP +0.9% (upgraded to Buy from Neutral at Citigroup), QGEN +0.6% (upgraded to Buy from Sell at DZ Bank)

Gapping down
In reaction to disappointing earnings/guidance: ZQK -12.4%, GPS -5.8%, ZUMZ -5.1%, FNSR -5%, SEAC -4.3%, BEBE -2.8%, BEBE -2.8%, COO -2.1%.

Other news: REPH -40.5% (announced that the Phase 2b clinical trial of Dex-IN for the treatmnet of acute post-operative pain is not expected to reach statistical significance at its current design), KORS -5.1% (Michael Kors files for ordinary share shelf offering by selling shareholders; launches secondary public offering of ordinary shares on behalf of Sportswear, one of its principal founding shareholders, for the offering of 11,629,627 ordinary shares), TUMI -4.4% (announced secondary offering of 8 mln shares of common stock by Doughty Hanson & Co. Managers Limited), PNNT -4% ( announces public offering of 11 mln shares of common stock), GLNG -3.5% (announces secondary offering of ~27.83 mln shares of its common stock by World Shipholding Ltd.), HMY -2.5% (still checking), ST -2.2% (announced offering of ~15.05 mln ordinary shares by selling shareholders), CX -2% (prices of €400 mln and $1.1 bln in Senior Secured Notes), SDRL -1.7% (still checking), AU -1.6% (still checking), GSK -1.5% (will not be able to fill all demand for flu vaccines, according to reports), GTAT -1.3% (cont vol due to speculation surrounding iPhone component), SHPG -1% (still checking).

Analyst comments: TTWO -1.3% (downgraded to Neutral from Buy at Sterne Agee), CS -1.1% (downgraded to Neutral from Buy at UBS), PCLN -0.7% (downgraded to Equal Weight from Overweight at Evercore ), MS -0.7% (downgraded to Neutral from Outperform at Macquarie).

Оригинал статьи: gtstocks.com/analytics-05-09-2014.html
08.09.2014, 13:42
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY на премаркете стоит в узком коридоре после гэпа вниз

Ближайший уровень поддержки по SPY – 200.80 уровень сопротивления – 201.00



DATA смотрим на продажу ниже 70

SPLK продажа ниже 59.50

NKE смотрим на продолжение роста

COST смотрим на покупку выше 127

NXPI покупка выше 71

Gapping up/down: MGAM +28% following merger with GCA, RAX +5% on M&A reports, FEYE +3% after upgrade; CPB -3% after earnings, UK stocks under pressure, F-2% after dg

Gapping up
In reaction to strong earnings/guidance: XCRA +2.1%

M&A news: MGAM +28.7% (to be acquired by Global Cash Access (GCA) for $36.50/share in cash), RAX +4.7% (CenturyLink (CTL) considering acquisition of RAX, according to reports)

Other news: MSTX +11.1% (announces positive top line results from Phase 2 study of AIR001), ISNS +7.3% (co and NuPark LLC announced that they have completed an integration and partnership agreement), ASTI +6.8% (files for 1 mln share common stock offering by selling shareholders), ALLT +5.1% (receives an expansion order of $15 mln from a Tier-1 Operator), HTZ +3.3% (announces Mark Frissora to step down as Chairman and CEO), BCRX +3.1% (announces RAPIVAB trial results for the treatment of influenza), YHOO +2.9% (rising in advance of BABA IPO release, also positive commentary on Mad Money), GLUU +2.7% (discloses it extended its licensing agreement with Kim Kardashian by three years), HIMX +1.9% (Google Glass on sale in GOOG Play store), NVAX +1.7% (presents data on RSV F Nanoparticle vaccine induced monoclonal antibody), GTAT +1.1% (Former GTAT employee Paul Matthews claims that GTAT sapphire covers are in AAPL iPhone 6, according to reports), SYN +1.1% (highlights SYN-005 data; SYN-005 neutralizing antibody combination protects against pertussis in murine and non-human primate models)

Analyst comments: INFN +4.6% (upgraded to Buy from Hold at Jefferies), FEYE +3.2% (upgraded to Buy from Neutral at UBS), MTRX +2.2% (upgraded to Buy from Hold at KeyBanc Capital Mkts), SGI +1.9% (upgraded to Buy at DA Davidson; tgt raised to $12), BAC +0.9% (upgraded to Buy from Neutral at Goldman), UBNT +0.9% (initiated with an Outperform at FBN Securities), TSLA +0.7% (initiated with an Outperform at FBN Securities), AIG +0.6% (initiated with a Buy at Citigroup)

Gapping down
In reaction to disappointing earnings/guidance: CPB -3.2%.

Select UK listed names showing weakness following sell-off in FTSE: LYG -4.7%, RBS -4.3%, GSK -3.7%, BCS -3.5%, AZN -2.4%, RDS.A -1.9%, HSBC -1.9%, BP -1.8%, SHPG -1.6%, RIO -1.5%, ING -1.3%

Other news: WRLD -7.7% (disclosed KPMG would not respond to recent request for proposal to serve as independent registered public accounting firm), DGLY -5.9% (cont volatility), AKS -3.4% (announces concurrent offerings of 35 mln shares common stock and senior unsecured notes with aggregate value of $430 mln), XON -2.9% (files mixed securities shelf offering), UEC -2.2% (files shelf offering for ~1.86 mln shares of common stock ), TKMR -1.7% (negative mention on Mad Money)

Analyst comments: KERX -6% (downgraded to Underperform at FBR Capital ), F -2.5% (downgraded to Underweight at Morgan Stanley), HMY -2.5% (initiated with a Neutral at JP Morgan), GOLD -1.6% (initiated with a Neutral at JP Morgan)

Оригинал статьи: gtstocks.com/analytics-08-09-2014.html
09.09.2014, 14:29
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY понизился на премаркете

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.90



CMGE продажа от 28.50

MSI продажа от 61

Gapping up/down: BURL +6% and CASY +4% after earnings/guidance, BNNY and IPAS +37% on M&A news, BNNY peers trading higher, MZOR +7% on CFDA approval, THLD +15% on initiation; FRAN -12%, TITN -11%, and FCEL -10% after earnings, POT -1% after dg

Gapping up
In reaction to strong earnings/guidance: BURL +6.1%, CASY +4.1%, TPLM +3.4%, KFY +3%, HELI +2.2%, HDS +1.9%, CTLT +1.1%.

M&A news:BNNY +37.4% (to be acquired by General Mills (GIS) for $46 per share in cash), IPAS +36.8% (to explore strategic alternatives), GFIG +7.2% (BGC Partners (BGCP) announces intent to commence all cash tender offer to acquire GFI Group Shares for $5.25 Per Share).

Select BNNY peers showing strength: WWAV +5.5%, BDBD +4.5%, HAIN +3.8%.

Select Mad Money mentions trading higher: ATK +2%, NFLX +1.6%, LMT +1.1%, RTN +0.9%, SKX +0.5%.

Other news: MZOR +6.8% (receives China CFDA approval for its Renaissance Systems), IDTI +4.8% (working closely with Intel (INTC) on the development of wireless charging solutions), NVFY +3.8% (announces purchase order fulfilled with IKEA China), STKL +3.6% (will further expand its Modesto, California aseptic processing and packaging operation), GTAT +3.1% (ahead of Apple's product event — speculation as supplier), HSOL +2.6% (signs its second supply agreement with Baotou Shansheng New Energy for delivery of 50 MW of HSOL's PV modules), PRTS +2.2% (named Michael Yoshida Interim Chief Financial Officer; co has initiated a search for a new CFO), ABB +2.1% (announces $4 bln share repurchase), SGMS +1.9% (awarded three-year instant game contract extension with Colorado lottery), ADXS +1.5% (announces completion of an End-of-Phase 2 Meeting with the FDA for its lead Lm-LLO cancer immunotherapy), GLYC +1.1% (announced that data from preclinical studies demonstrating the in vivo efficacy of GMI-1051 will be presented), IMMR +1% (following late move higher on increased volume), MITK +1% (announced that it has agreed to end all pending litigation with Top Image Systems (TISA) andTIS America), JCP +1% (subsidiary commences underwritten public offering of $350 mln aggregate principal amount of senior unsecured notes), LPCN +0.9% (announces first patient dosed in Phase 1 study in pregnant women of LPCN 1107, potentially the first oral product for the prevention of preterm birth), AAPL +0.7% (trading higher in advance of product event).

Analyst comments: THLD +15% (initiated with a Buy at Cantor Fitzgerald), CTIC +9.7% (initiated with a Overweight at Piper Jaffray), ECYT +5.5% (initiated with a Buy at Cantor Fitzgerald), CEMP +4.2% (receives $10 mln milestone payment from Toyama Chemical Co), MACK +3.5% (initiated with a Buy at Cantor Fitzgerald ), MBLY +3.4% (hearing positive Morgan Stanley comments as catalyst), SYF +3.2% (initiated with a Overweight at JP Morgan and Morgan Stanley, among others), GCA +2.8% (upgraded to Buy at Stifel following MGAM purchase), LYG +2.3% (upgraded to Overweight from Neutral at HSBC Securities), MT +1.9% (upgraded to Outperform from Neutral at Credit Suisse), VRTU +1.7% (upgraded to Overweight from Neutral at JP Morgan), BCS +1.6% (upgraded to Overweight from Neutral at HSBC Securities), MDVN +1.4% (upgraded to Outperform from Mkt Perform at Bernstein), AMRI +1.3% (initiated with a Overweight at JP Morgan), DHI +1.2% (upgraded to Overweight from Neutral at JP Morgan)

Gapping down
In reaction to disappointing earnings/guidance: FRAN -11.7%, TITN -10.7%, FCEL -10.5%, PBY -7.1%, CNSI -5%, FUEL -2.4%, (announces CFO transition and reaffirms prior guidance for the 3Q14 and FY14 ), PTN -1%.

Other news: RADA -5.5% (following 130%+ surge higher following intraday earnings release), AVP -4.1% (announced resignation of CFO Kimberly Ross; Robert Loughran appointed acting CFO effective October 2, 2014), PF -3.7% (announced secondary offering of 15 mln shares of common stock by selling shareholders), DOC -2.6% (announced public offering of 9 mln shares of common stock; announces over $300 mln of commitments for new unsecured revolving credit facility), BKD -1.7% (prices public offering of 8,955,223 shares of Common Stock at $33.50/share), TNET -1.3% (announced commencement of secondary public offering of 10,500,000 shares by stockholders), AKS -1.3% (still checking), WBAI -0.9% (late weakness on cautious Muddy Waters mention).

Analyst comments: LUV -1.1% (initiated with a Neutral at Credit Suisse), POT -1% (downgraded to Underperform from Mkt Perform at Cowen), MOS -0.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts), JBLU -0.7% (initiated with a Underperform at Credit Suisse), CVX -0.7% (downgraded to Underperform from Neutral at BofA/Merrill).

Оригинал статьи: gtstocks.com/analytics-09-09-2014.html
10.09.2014, 14:00
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY топчется на месте

Ближайший уровень поддержки по SPY – 199.25 уровень сопротивления – 199.75



THC продажа ниже 61

BITA покупка при удержании 82

NPSP продажа от 30

Gapping up/down: PANW +5% after earnings, CLF +2% on amended credit facility, TWTR +3% after upgrade; KKD -5% after earnings, AU -12% on restructuring announcement, GTAT -6% on dg at GS

Gapping up
In reaction to strong earnings/guidance: MNDL +10.2%, LMNR +8.1%, DIOD +6.8%, PANW +5.3%, LE +5%, UNIS +4.6%, PPHM +3.2%, PDLI +3.1%, SIRI +1.1%, IHT +1%, SAIC +0.5%.

M&A news: IMPV +2.8% (Imperva, TIBX, TDC among possible takeover targets by HP (HPQ), according to reports), EXPR +1.2% (Barron's mentions name as M&A target), FDO +0.3% (Dollar General (DG) commences cash tender offer to acquire FDO at $80 per share).

Select EU bell weather names showing strength: BP +1.7%, ING +1.2%, DB +0.9%, RDS.A +0.9%, ALU +0.6%.

Select Biotech stocks trading higher: MNOV +13.3%, NPSP +13% (following FDA briefing docs), TKMR +3.2%, SPPI +2.4%, ACHN +1%.

Other news: DRL +12.4% (announces the sale of ~$430 mln in assets), PVCT +7.5% (still checking), BDBD +6.8% (favorable commentary on Tuesday's Mad Money), SUPN +6.2% (Orchard Hill Capital Management files amended 13D; request that the Board hires a strategic advisor to consider selling the Company), BWEN +4.1% (announced $14 million in new tower orders from a U.S. wind turbine manufacturer), RADA +3.9% (cont momentum), SUNE +3.6% (Google (GOOG) executes $145 million investment in SunEdison and TerraForm Power's (TERP) largest solar plant in North America), GPRO +3% (still checking), CLF +1.8% (amended revolving credit facility to allow for $200 mln share repurchase program), FEYE +1.5% (in sympathy with PANW earnings), LTM +1.2% (favorable commentary on Tuesday's Mad Money), TFSL +1.1% (authorizes the purchase of up to 10,000,000 shares of the Company's outstanding common stock), THOR +1.1% (announced start of Heartmate III U.S. clinical trial) CRM +1% (signs agreement to establish new european data centre in France; selects Interxion (INXN) as service provider), HAIN +1% (favorable commentary on Tuesday's Mad Money), TSL +1% (to supply 70MW high efficiency modules to a large-scale solar power project in Chile), KFRC +1% (announces increase to board share buyback authorization by $70 mln).

Analyst comments: TWTR +2.7% (upgraded to Buy from Neutral at UBS), LB +0.9% (upgraded to Outperform from Neutral at Credit Suisse), COH +0.8% (upgraded to Overweight from Neutral at Atlantic Equities), TPLM +0.8% (upgraded to Buy from Accumulate at KLR Group)

Gapping down
In reaction to disappointing earnings/guidance: MGCD -9.7%, KKD -5.2%, URBN -2%, (Thus far during the third quarter of fiscal 2015, comparable Retail segment net sales are low single-digit negative), CBSO -1.8%, CRDS -1.7%, MANU -0.7%.

Other news: AU -11.9% (to explore the possibility of restructuring co into simpler and more focused entities), RSH -10.6% (cont weakness following Wedbush target cut to $0), AHH -5.7% (announces public offering of 5 mln shares of common stock), WBAI -5.4% (Muddy waters follow up from Value Walk), ACT -2.8% ( negative vote from the FDA's Cardiovascular and Renal Drugs Advisory Committee regarding NDA for nebivolol/valsartan for the treatment of hypertension), SCOK -2.8% (modestly pulling back after yesterday's advance), AVB -2.4% (announces offering of 4.5 mln shares of common stock), GFI -1.8% (may be in sympathy with AU), EQY -1.6% (announced 3.825 mln share public offering of common stock), STM -1.5% (potentially related to Apple (AAPL) event), TI -1.4% (América Movil (AMX) and Telefonica (TEF) among cos that are close to bid for Telecom Italia's (TI) Brazil operations, according to reports), ARMH -1.1% (potentially related to Apple (AAPL) event).

Analyst comments: GTAT -6.4% (downgraded to Neutral from Buy at Goldman), BYD -3.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley), MBLY -2.8% (downgraded to Hold from Buy at Deutsche Bank on valuation), EBAY -1.3% (downgraded to Neutral from Overweight at Piper Jaffray), SAVE -1.2% (downgraded to Mkt Perform from Outperform at Cowen), TIF -0.8% (downgraded to Neutral from Outperform at Credit Suisse), AAPL -0.6% (downgraded to Sector Perform from Outperform at Pacific Crest).

Оригинал статьи: gtstocks.com/analytics-10-09-2014.html
11.09.2014, 14:14
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY падает на премаркете

Ближайший уровень поддержки по SPY – 199.00 уровень сопротивления – 199.70



LE продажа от 40

EMES покупка выше 130

SLCA покупка выше 70

UTHR продажа от 122

GPRO покупка выше 69

Gapping up/down: JDSU +14% after guidance/spin-off announcement, LULU +14% after earnings, GPRO +3% after gt raise; RH -4% after earnings, energy and metals tradind lower, CROX -3% after dg

Gapping up
In reaction to strong earnings/guidance: GRO +19.4%, JDSU +14%, (reaffirms; to Separate into Two Industry-Leading Public Companies), LULU +13.6%, SIGM +10%, LFVN +8%, WTSL +5.9%, MBUU +5.1%, BRC +3.1%, RSH +2.2%

M&A news: RAX +0.9% (cont M&A spec)

Other news: IMRS +19.7% (neurosurgical HFD rocker arm receives FDA clearance), DGLY +12.8% (to introduce 'Bullet Camera' option for FirstVU HD body camera system at IACP conference), LAND +7.7% (announces REIT Election), GOGO +5.4% (Gogo and T-Mobile (TMUS) to deliver free in-flight texting and voicemail to T-Mobile customers), RXII +4.5% (presented an update on the company's dermatology and ophthalmology franchises), PT +3.8% (still checking), FNSR +3.6% (following JDSU news/guidance), GPRO +3.3% (favorable commentary on Wednesday's Mad Money), SOL +2.1% (to supply 10MW DCR solar modules to Utility-Scale project in India), POWR +1.9% (disclosed it acquired the electrical contracting business of Apex Controls), MDVN +1.4% (FDA approves new indication for the use of XTANDI (enzalutamide) capsules for patients with metastatic castration-resistant prostate cancer), MBLY +1.4% (still checking), EXXI +1.2% (Energy XXI late spike attributed to speculation of Gulf of Mexico asset sale), GTAT +1.2% (modestly rebounding), EMC +1.2% (reports of VMW stake sale), TWX +0.9% (does not have plans for HBO spin off, 'seriously' looked at Fox (FOXA) offer, CEO said, according to reports)

Analyst comments: GPRO +3.3% (target raised to $70 from $42 at Citigroup), NES +2% (initiated with a Buy at Stifel), SEAS +1.5% (upgraded to Outperform from Neutral at Macquarie), PBR +1.3% (initiated with an Outperform at Cowen), TS +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), TCAP +0.7% (upgraded to Outperform from Market Perform at Wells Fargo), JLL +0.6% (upgraded to Overweight from Neutral at JP Morgan), GDP +0.6% (initiated with an Outperform at Cowen)

Gapping down
In reaction to disappointing earnings/guidance: EOPN -28.6%, (updates guidance; announces that three customers will not be renewing contracts; names new head of sales organization ), SYMX -22.9%, DLIA -13%, FIVE -5%, RH -3.8%

Select China related names showing weakness: CAAS -8.8%, CSUN -4.7%, CGA -4.5%, MY -4.5%, VIPS -2%

Select metals/mining stocks trading lower: HMY -2.6%, MT -1.4%, SLV -1.2%, FCX -1.2%, SLW -1.1%, GOLD -0.9%, GG -0.8%, ABX -0.7%

Select oil/gas related names showing early weakness: E -2.4%, RIG -1.6%, BHP -1.6%, SSL -1.6%, STO -1.3%, TOT -1.2%

Other news: INVE -17.4% (announces proposed stock offering ), ASTM -4.4% (announces pricing of public offering of 13,725,490 shares of Common Stock at $2.55/share), NETE -3.7% (following 100%+ move higher yesterday). NBR -3.6% (hearing Activist investor may be selling shares, according to article), TEF -1.9% (still checking), TWTR -1.6% (announces $650 mln convertible unsecured senior note offering; announces amendment to revolving credit agreement)

Analyst comments: CROX -3.7% (downgraded to Neutral from Buy at Buckingham Research), M -1.8% (downgraded to Neutral from Buy at Sterne Agee)

Оригинал статьи: gtstocks.com/analytics-11-09-2014.html
12.09.2014, 11:46
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
Снижение тарифов на торговом терминале Takion

Компания GT Capital Group рада сообщить вам о снижении тарифов для новых трейдеров на торговом терминале Takion. Так же сумма минимального депозита составляет всего 500$. Мы надеемся, что новые условия сделают для вас доступнее фондовый рынок США.

Ознакомиться с новыми тарифами

В ближайшие недели у нас будет еще несколько нововведений которые должны порадовать трейдеров.

Стоимость торгового терминала Takion может быть уменьшена по согласованию с менеджером.
12.09.2014, 14:23
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1
SPY слегка снижается

Ближайший уровень поддержки по SPY – 200.00 уровень сопротивления – 200.40



LULU продажа от 44

LE продажа ниже 45

WB продажа от 25

VSI продажа от 44

DATA продажа от 76.50

VNET покупка от 16

Gapping up/down: ULTA +16% and DRI +3.5% after earnings, CNVR +32% after merger with ADS +2.4%, NFLX +0.7% after upgrade; CHKE -8% after earnings

Gapping up
In reaction to strong earnings/guidance: ULTA +16.1%, CGA +8.3%, SPWH +7.6%, CVTI +7.6%, DRI +3.5%, NTWK +3%

M&A news: CNVR +32.6% (Alliance Data to acquire Conversant), ADS +2.4%

Other news: ASTI +11.5% (regains compliance with NASDAQ minimum bid price rule), STRI +11.5% (still checking), XPO +8.7% (announced a $700 mln investment by PSP Investments, GIC, Singapore's sovereign wealth fund, and Ontario Teachers' Pension Plan; co also raised its FY17 financial targets), LXRX +8.4% (announced a publication in the American Diabetes Association's Journal), ACAD +4.8% (favorable commentary on Thursday's Mad Money), FUEL +4.4% (following late spike into the close), HTZ +4.2% (Hertz Global reaches an agreement-in-principle with Carl Icahn to add Three Directors), VNET +4% (cont volatility), RMTI +3.9% (still checking), CRTO +3.7% (following late move higher), BTX +3.7% (co's subsidiary reached an agreement with Cancer Research UK and Cancer Research Technology for a clinical trial of immunotherapy vaccine for lung cancer), TASR +2.9% (favorable commentary on Thursday's Mad Money), ISIS +2.7% (favorable commentary on Thursday's Mad Money), SCOK +2.5% (following 18% move higher yesterday), OREX +2.3% (mentioned positive on CNBC's Fast Money), NVO +2.1% ( FDA's Endocrinologic and Metabolic Drugs Advisory Committee votes 14-1 in favor of recommending approval of liraglutide for chronic weight management ), BCS +2.1% (John McFarlane appointed to succeed Sir David Walker as Chairman), WWAV +1.8% (cont M&A spec), TNET +1.6% (prices 12 mln shares of common stock at a price of $25.50 per share ), S +1.5% (announces exclusive new rate plan for iPhone 6 and iPhone 6 plus and a revolutionary new way to acquire iPhone, also upgraded to Outperform from Mkt Perform at Cowen), FEYE +1.1% (cont volatility), HDS +1% (announces sale of 20,000,000 shares of common stock by selling stockholders)

Analyst comments: NLNK +4.9% (initiated with a Buy at Mizuho), TMUS +1% (upgraded to Buy from Hold at Argus), IRC +0.9% (upgraded to Buy from Hold at KeyBanc Capital Mkts), NFLX +0.7% (upgraded to Equal Weight from Underweight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: CHKE -7.9%

Select metals/mining stocks trading lower: GFI -2.5%, HMY -1.1%, GOLD -1%, IAG -0.5%.

Other news: ACHN -3.3% (negative commentary on Thursday's Mad Money), HCN -3.1% (announces proposed offering of 15,500,000 shares of common stock), SDRL -2.8% (still checking), PPL -1.9% (Federal Appeals Court sides with PPL, affirms New Jersey Court decision invalidating state legislation subsidizing new power plants), AMAT -1.4% (unfavorable China's Ministry of Commerce determination in Tokyo Electron deal), KATE -1.1% (negative commentary on Thursday's Mad Money)

Analyst comments: RKUS -4.5% (initiated with a Underweight at Morgan Stanley), DDR -3.5% (downgraded to Hold from Buy at KeyBanc Capital Mkts, downgraded to Neutral from Buy at UBS)

Оригинал статьи: gtstocks.com/analytics-12-09-2014.html
16.09.2014, 13:51
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY консолидируется на премаркете

SPY консолидируется на премаркете

Ближайший уровень поддержки по SPY – 198.65 уровень сопротивления – 198.90



AVNR продажа ниже 12

CAB покупка на продолжение тренда вверх

YY покупка при удержании 80

WDAY покупка выше 86

UBNT покупка выше 43

Gapping up/down: SODA +4% on M&A related news, VNET +4%, AEO +2% and DATA +2% on upgrades/initiations; ALOG -3.5% after earnings, Casino names trading lower, ACI -2% after dg

Gapping up
In reaction to strong earnings/guidance: SINO +33.1%, (surged higher into the close after reporting earnings in late trade), FONR +9.2%, AXR +3.5%

M&A news: SODA +4.2% (in discussions with British fund regarding sale, according to reports)

Other news: RWLK +5.9% (cont momentum following IPO), PSTI +5.9% (pursues development strategy in Japan where new law accelerates path to market), SSH +5.5% (to provide clinical updates from the North American feasibility study), UEC +5% (reports positive preliminary economic assessment on Anderson Project in Arizona), OREX +3.9% (after seeing notable late move off lows on insider buy disclosures), AXAS +2.3% (raises Q3 production guidance to 6.9-7.0 Boepd, up from 6.5-6.7 Boepd), JDSU +1.9% (favorable commentary on Monday's Mad Money), CSIQ +1.1% (announces 1.5 MW solar module supply agreement in Jordan), YNDX +1.1% (modest rebound after yesterday's decline)

Analyst comments: DRYS +5.2% (initiated with a Buy at Deutsche Bank), VNET +4.4% (upgraded to Outperform from Sector Perform at Pacific Crest), STRI +4.1% (upgraded to Buy at Craig Hallum), GASS +3.5% (initiated with a Buy at Deutsche Bank), AEO +2% (upgraded to Overweight from Equal Weight at a boutique firm), DATA +1.8% (upgraded to Outperform from Neutral at Credit Suisse), DSX +1.4% (initiated with a Buy at Deutsche Bank), TNK +1.3% (initiated with a Buy at Deutsche Bank), TAP +1.3% (initiated with an Outperform at Cowen), CPLP +1% (initiated with a Buy at Deutsche Bank), TEX +0.9% (upgraded to Buy at Stifel)

Gapping down
In reaction to disappointing earnings/guidance: COOL -13.7%, (thinly traded), FULL -4.7%, ALOG -3.5%, PARN -2.5%

M&A news: AT -18.9% (provides update on outcome of strategic review process; sale or merger of co not in best interests of co or its stakeholders at this time), BUD -1.6% (WSJ says Anheuser-Busch InBev seeking financing for SABMiller plc (SBMRY) deal), ORAN -1.4% (Group will launch a friendly voluntary cash tender offer for the acquisition of 100% of the capital of Jazztel)

Select EU heavy-weight names showing weakness: ALU -1.5%, AZN -1.4%, BCS -1.1%, ARMH -0.8%, DB -0.7%, LYG -0.6%

Select Casino stocks trading lower: MGM -3%, LVS -2.4%, WYNN -1.8%, CNTY -1.5%, BYD -0.9%

Other news: SIGA -27.1% (files for Chapter 11 reorganization), PIP -15.9% (still checking), OPXA -10.2% (announces proposed public offering of common stock), OXPA -10.2% (still checking), GST -7.9% (announced that it intends to offer 17 mln shares of its common stock ), AVNR -6.7% (modest pull back following yesterdays 80%+ advance), CHA -3.2% (Shanghai -1.8% overnight), CHL -2.9% (Shanghai -1.8% overnight), ACI -2.1% (China plans to ban low grade coal, according to reports), NFLX -1.8% (FCC to consider net neutrality for mobile broadband, according to reports), BTU -1.2% (China plans to ban low grade coal, according to reports), GPRO -1.1% (cont pre-mkt vol), AA -1% (announces proposed public offering of 25 mln depository share of Mandatory Convertible Preferred Stock)

Analyst comments: ACI -2.1% (downgraded to Reduce from Neutral at Nomura), CMI -1.2% (downgraded to Market Perform from Outperform at Wells Fargo), BTU -1.2% (downgraded to Reduce from Neutral at Nomura), SAP -1.1% (initiated with a Sector Perform at RBC Capital Mkts), YOKU -0.8% (hearing cautious OTR mention), OXY -0.6% (downgraded to Equal Weight from Overweight at Barclays), ADBE -0.6% (assumed with a Sector Perform (down from Outperform) at RBC Capital Mkts)

Оригинал статьи:
gtstocks.com/analytics-16-09-2014.html
17.09.2014, 13:20
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY незначительно снижается на премаркете

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.65



HUM продажа от 132.50

LCA продажа ниже 71

GILD продажа от 105

DLPH покупка от 67.20

VXX покупка от 27.80

Оригинал статьи: gtstocks.com/analytics-17-09-2014.html
18.09.2014, 12:20
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию Тариф старт

Мы рады сообщить вам о новом тарифе «Старт» для тех кто только хочет начать торговать на фондовой бирже США. До нового сезона отчетов, осталось всего пару недель и вы успеете попробовать свои силы в самый активный период времени на рынке, когда профессиональные трейдеры зарабатывают больше всего денег. Не упустите свой шанс!

Условия акции:

Для депозитов от 500 до 1000$ комиссия будет всего 0,6$ за 100 акций. Для депозитов больше 1000$ комиссия 0,4$ за 100 акций. Акция проходит на торговой платформе Fusion и не распространяется на другие торговые терминалы. Срок проведения акции до 1 октября. Акция действуйте, только на новые счета.

Успейте открыть счет и торгуйте на выгодных условиях!

Оригинал статьи: http://gtstocks.com/tariffstart2014.html
18.09.2014, 13:38
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY продолжнает расти

Ближайший уровень поддержки по SPY – 200.50 уровень сопротивления – 201.65



FDX продажа от 160

DRC смотрим на продажу

ALNY продажа от 78

X продажа от 46

DD покупка при удержании 69.50

KSU продажа ниже 122

SKX покупка от 59

CPA покупка при удержании 113, ниже продажа

Gapping up/down: STLD +5% and CAG +3% after earnings/guidance, EMKR +45% after sale of Space Photovoltaics biz, KSS +1% after upgrade; PIR -13% and RAD -7% after earnings, DNR -2% after dg

Gapping up
In reaction to strong earnings/guidance: PWE +8.1%, ROSG +5.4%, STLD +4.6%, MLHR +3.4%, CAG +2.8%, UNFI +2%, CLC +1.6%

M&A news: SODA +3.1% (story making the rounds suggesting M&A from DEO, KKR or SBMRY), SNN +1.9% (renewed M&A spec post Stryker (SYK) analyst meeting), WWAV +1.8% (acquires So Delicious Dairy Free for ~$195 mln in cash)

Other news: EMKR +45.7% (announces the sale of its Space Photovoltaics Business to Veritas Capital, announces CEO transition plan), BAXS +20% (to explore strategic alternatives for its MIS Spine Business), XXII +18.7% (enters cannabis space; acquires exclusive U.S. license to Cannabinoid Biosynthesis Genes and takes 25% stake in biotechnology company), VVUS +17.8% (Vivus and Auxilium (AUXL) announce FDA approval of STENDRA sNDA), WYY +8.4% (subsidiary iSYS receives task order from U.S. Citizenship and Immigration Services), RSH +8.2% (cont pre-mkt vol), CGEN +4.2% (still checking), GILT +3.3% (still checking), SONS +3.3% (board of directors voted to terminate the co's shareholder rights plan effective Sep 17, 2014), MOBI +3.2% (announces strategic partnership with China Telecom (CHA)), ERIC +3.2% (announced it will discontinue future development of modems and shift parts of resources in modems to radio network R&D ), NETE +3% (CEO Oleg Firer discloses 6.5% stake), STM +1.9% (may be moving with ERIC), A +1.8% (transition of CEO: Mike McMullen to succeed Bill Sullivan in March 2015; creates new group for services and consumables), CY +1.7% (favorable commentary on Wednesday's Mad Money), ISIS +1.7% (favorable commentary on Wednesday's Mad Money), YHOO +1.2% (cont momentum ahead of BABA IPO), X +0.9% (in sympathy with STLD), OVTI +0.8% (Hua Capital Management hired bankers to fund possible OVTI bid, according to reports), INFY +0.6% (announced a global partnerships with Huawei, MSFT, and Hitachi for various products/svcs), AAPL +0.6% (iPhone 6 has received 1 China license, according to reports)

Analyst comments: IOC +4.1% (initiated with a Outperform at Credit Suisse), TKMR +2.4% (positive commentary at Maxim), VNCE +1.6% (initiated with a Buy at B. Riley & Co), KSS +1.3% (upgraded to Buy from Neutral at Citigroup), RYI +1.1% (initiated with a Buy at KeyBanc Capital Mkts), MON +1% (upgraded to Buy at Stifel), MT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), DD +0.7% (upgraded to Overweight from Neutral at JP Morgan), BXP +0.6% (upgraded to Buy at Stifel), BA +0.5% (added to Franchise Pick list at Jefferies)

Gapping down
In reaction to disappointing earnings/guidance: PIR -12.8%, MCHX -10.9%, RAD -7.5%, CLR -1.4%, GDOT -0.7%


Other news: ECTE -4.9% (Therapeutics Platinum seeks return of $5 mln investment in Echo Therapeutics), SNE -4.8% (cont weakness following Japan session (guided downward yest)), AVNR -1.5% (cont volatility after the the large move this week), ENDP -0.8% (pulling back modestly following yesterday's merger annoncement of AUXL), VNET -0.5% (posted its second response to short seller, rejects the baseless allegations)

Analyst comments: DNR -2.1% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)

Оригинал статьи: http://gtstocks.com/analytics-18-09-2014.html
19.09.2014, 14:09
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY открывается гэпом вниз

Ближайший уровень поддержки по SPY – 201.25 уровень сопротивления – 201.75



Сегодня крупнейшее IPO компании Alibaba (тикер BABA). Подробнее можно почитать тут: gtstocks.com/forum/viewtopic.php?f=38&t=31&p=61#p61

CPA покупка выше 77.50

CRR смотрим на откат после гэпа

Gapping up/down: CNQR +19% after merger with SAP (-4%), YHOO +2% ahead of BABA IPO, GLNG +4% after upgrade; TIBX, VMI, and ORCL -3% after earnings, ESI -15% following Wells Notice, CRR -6% after dg at GS Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: PDEX +28.6%

M&A news: CNQR +19.4% (to be acquired by SAP subsidiary, SAP America, for $129 per share), DRC +12.1% (following reports that company may receive $80/share bid from Siemens (SI)), LULU +1.6% (Keybanc discussed VFC exec comments suggesting possible LULU deal)

Select Apple value chain related names showing strength: RFMD +1.3%, SWKS +1%, AVGO +0.8%, NXPI +0.7%

Select China related names showing strength ahead of BABA IPO: WB +1.7%, JD +1.1%, BIDU +0.8%

Other news: NAVB +10.5% (confirms it received Orphan Drug Designation from FDA for Use of Lymphoseek in Head and Neck Cancers), MCP +5.3% (Oaktree Capital Mgmt discloses 9.1% stake in 13G), HIMX +4.2% (climbed higher into the close after analyst suggested Google may replace Samsung OLED displays with Himax), JBLU +4.2% (announced that Robin Hayes, the company's current President, will succeed Dave Barger as CEO, effective February 16, 2015), INVN +3.4% (reports indicate that iPhone 6 contains InvenSense MP67B 6-axis Gyroscope), EMES +2.6% (initiated with a Buy at Goldman), MGA +2.5% (announces cooperation regarding regulatory investigation), SHLD +2.3% (Fairholme Capital Management disclosed 24% active stake in 13D filing), RBS +2.1% (following result of Scottish referendum), YHOO +1.9% (trading higher in advance of BABA IPO, also target raised to $48 from $44 at Piper Jaffray, tgt raised to $43 from $39 at Cantor Fitzgerald), WEN +1.7% (Trian Fund Management reports 24.39% stake in amended 13/D filing), RAD +1.5% (favorable commentary on Thursday's Mad Money), AMD +1.3% (co and Synopsys expanded their IP partnership), GILD +1.2% (announces European Commission granted marketing authorization for co's Zydelig), VOD +0.8% (in relation to Vivendi (VIVHY) authorized agreement with Telefonica (TEF) concerning the acquisition of GVT), GSK +0.8% (announces China investigation outcome; will pay a fine of GBP297 mln), HTZ +0.8% (China Partner, CAR Inc. announces IPO), NFLX +0.5% (officially launches in France, Germany, Austria, Switzerland, Belgium And Luxembourg)

Analyst comments: GLNG +4.5% (target raised to $110 from $75 at BofA/Merrill), FRAN +2.6% (upgraded to Buy from Neutral at Buckingham Research), AEO +2.4% (upgraded to Buy from Neutral at Goldman), NVAX +2.2% (assumed with an Outperform at Wedbush), ZION +1.2% (upgraded to Strong Buy from Outperform at Raymond James), VFC +1% (upgraded to Buy from Hold at KeyBanc Capital Mkts), FEYE +1% (target raised to $40 from $36 at Piper Jaffray), AMZN +0.8% (target raised to $435 at RBC Capital Mkts)

Gapping down
In reaction to disappointing earnings/guidance: TIBX -3.6%, VMI -3.2%, ORCL -2.8%, (also appoints Larry Ellison Executive Chairman and CTO; Larry Ellison steps down as CEO )

M&A news: SAP -4.1% (acquiring CNQR for $129 per share)

Select metals/mining names showing weakness: GFI -1.6%, RIO -1.5%, MT -1.3%, HMY -1.2%, IAG -0.9%, BHP -0.7%

Other news: ESI -15% (disclosed it received Wells Notice), QRHC -14% (announced proposed public offering), EROC -4.5% (filed for ~53.34 mln unit offering of common units representing limited partner interests by selling unitholders), STM -3.9% (still checking), CLDT -3.1% (launched public offering of 5 mln common shares), BXMT -2.7% (announces public offering of class A common stock), SNE -2.2% (continued weakness following guiding earlier this week), GLUU -1.9% (filed for ~9.98 mln share common stock offering by selling shareholders), TOT -1.5% (received offer from Arkema (ARKAY) to acquire its Bostik affiliate; offer values Bostik at EUR1.74 bln), MITK -0.8% (disclosed Chief Marketing Officer, Scott Carter, is leaving the co)

Analyst comments: CRR -6.3% (downgraded to Sell from Neutral at Goldman), AUXL -4% (downgraded to Neutral from Buy at Goldman), SDRL -1.2% (downgraded to Underperform from Neutral at Exane BNP Paribas)

Оригинал статьи: gtstocks.com/analytics-19-09-2014.html
22.09.2014, 14:27
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY отыграл гэп вниз на премаркете

Ближайший уровень поддержки по SPY – 199.85 уровень сопротивления – 200.60



CNQR смотрим на падение

COL продажа от 80

CRR смотрим на покупку от 76

MGA покупка выше 104

Gapping up/down: SIAL +35% and VIAS +30% on M&A news, ALLT +1% after securring 3 new orders; metals and miners trading lower, MTL -34% after Russia's Economy Minister suggesting bankruptcy is most likely scenario, YHOO -3% after dg's Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: LCI +1%, (also announces launch of Oxycodone Hydrochloride Oral Solution)

M&A news: SIAL +34.9% (Germany's Merck KGaA (MKGAY.PK) to acquire SIAL for $140 per share in cash), VIAS +30.3% (TTM (TTMI) will acquire Viasystems for a combined consideration of $11.33 in cash and 0.706 shares of TTM common stock, or $16.46/share), VSI +2.7% (positive mention in Barron's suggesting the company as possible takeover target), CLX +2.7% (rejected takeover offer at 20% premium prior to news CEO will step down, according to reports), EMC +1.8% (may have had merger related discussions with HP (HPQ), according to reports)

Other news: CNET +6.6% (cont strength), TATT +5.3% (signed a seven year landing gear Maintenance Support Agreement with Republic Airways Holdings (RJET)), DRL +3.8% (states that after two days of trial, Hacienda has put forth no evidence), RSH +3.3% (had discussions with a major vendor concerning potential modifications to the commercial relationship), TTM +2.8% (still checking), INO +2.7% (expands HPV Immunotherapy development to aerodigestive cancers), DRC +2.1% (signs agreement to sell to Siemens (SIEGY) for $83.00 per share in cash), ALLT +1.4% (secures three orders from major cloud providers), ADHD +1% (announces completion of all patient visits in Phase 3 clinical trial of MDX in adult ADHD), AAL +1% (American Airlines and the Association of Professional Flight Attendants reach tentative agreement)

Analyst comments: ORBC +0.8% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: TRS -3%, (lowered FY14 EPS guidance; announced acquisition of Allfast Fastening Systems for $360 mln)

M&A news: AUXL -0.8% (provides transaction update; unanimously determined unsolicited, non binding offer from Endo Intl (ENDP) is not a superior proposal under the terms of its existing merger agreement with QLT (QLTI))

Select metals/mining stocks trading lower: RIO -2.2%, VALE -2%, BHP -1.8%, IAG -1.6%, SLV -1%, MT -0.7%

Other news: MTL -34.5% (reports of Russia's Economy Minister suggesting bankruptcy is most likely scenario), COCO -6.3% (received a grand jury subpoena for documents in Florida and Georgia), CRR -5.3% (provides marketplace update), STM -3.7% (still checking), ECTE -3.5% (Newly elected Board members to host conference call to provide shareholder update on Monday, September 22), AMRN -3.1% (may be in symp with INVN dg), ACHN -3% (may be in symp with INVN dg), CRDS -2.6% (files registration statement for proposed offering of Series H preferred stock and warrants to purchase common stock), CNHI -2% (announces plans to issue notes denominated in Euro), TSLA -1.2% (still checking; may be attributed to JPM comments preferring F and GM shares)

Analyst comments: INVN -3.3% (downgraded to Neutral from Outperform at Robert W. Baird), YHOO -3.1% (downgraded to Neutral from Buy at BofA/Merrill, to Mkt Perform from Outperform at Bernstein), RLGY -2.1% (downgraded to Underperform from Neutral at Credit Suisse), LVS -1.7% (downgraded to Market Perform from Outperform at Wells Fargo), VMI -1.5% (downgraded to Neutral from Buy at Sterne Agee), LNN -1.1% (downgraded to Neutral from Buy at Sterne Agee), WAG -0.9% (downgraded to Equal Weight from Overweight at Barclays), WYNN -0.8% (downgraded to Market Perform from Outperform at Wells Fargo), MPEL -0.8% (downgraded to Market Perform from Outperform at Wells Fargo).

Оригинал статьи: gtstocks.com/analytics-22-09-2014.html
07.10.2014, 14:18
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY продолжает вчерашнюю коррекцию

Ближайший уровень поддержки по SPY – 195.00 уровень сопротивления – 196.00



LRCX продажа от 75

WLP покупка от 119

DWRE продажа ниже 58

Gapping up/down: SIMO +15% and CAMP +7% after earnings, FEYE +6% after new partnerships; GMCR +2% on upgrade at GS; SODA and TCS -15% after earnings/guidance; LVS -3% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: SIMO +14.9%, CAMP +7.2%, ISCA +4.9%, NLNK +1.9%, IDT +0.6%

Select Ebola related names showing strength: CMRX +3.9%, TKMR +3.4%, LAKE +2.8%

Select metals/mining stocks trading higher: IGLD +2.5%, IAG +0.8%, CDE +0.8%, SVM +0.6%

Other news: GTAT +15% (modest retracement following yesterday's massive decline), MAGS +15% (receives $8.2 mln of new orders; majority of the contracts are for expansions, changes and upgrades of existing homeland security installations in Israel), XCO +10.6% (announces sale of interests in Compass Production Partners), BCLI +9% (FDA grants fast track designation to NurOwn for the treatment of ALS), OXGN +8.3% (announced that data from the Phase 2 GOG186I study of fosbretabulin in combination with bevacizumab will be presented on November 9 at the International Gynecologic Cancer Society), GSAT +7.1% (issues statement in response to Kerrisdale Capital presentation), FEYE +5.8% (FireEye and SingTel partner to launch first managed defense solution; also, announced targeted attack protection for the Apple (AAPL) platform), BCRX +2.4% (announces late breaker presentation of OPuS-1 Phase 2 Trial results at the 23rd EADV Congress will be present Oct 11), ADHD +2.3% (after yesterday's 57% decline), ACHN +1.8% (disclosed it entered into a Master Security Agreement for a $1,000,000 Capital Expenditure Line of Credit), SBLK +1.6% (collected $8.016 mln from the sale of its claim against PAN OCEAN), REGN +1.3% (EYLEA (aflibercept) Injection received FDA approval for macular edema following retinal vein occlusion), PSTI +1.3% (wins cell therapy patent case in Europe; European Patent Office confirms validity of amended claims )

Analyst comments: ADHD +2.3% (upgraded to Outperform at FBR Capital), NDLS +2.1% (upgraded to Buy from Hold at Jefferies), AUY +2.1% (upgraded to Neutral from Underweight at HSBC Securities), GMCR +1.9% (initiated with a Buy at Goldman), KPTI +1.1% (initiated with a Outperform at Wedbush), IP +1.1% (upgraded to Buy from Neutral at BofA/Merrill), CCK +0.7% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: SODA -15.1%, TCS -14.6%, EZPW -13.6%, CBK -11.8%, AEGN -9.3%, AGCO -8.7%

M&A news: RIO -1% (issues statement regarding press speculation surrounding Glencore (GLNCY))

Notable EU names showing weakness: ORAN -2.2%, DB -2.1%, NOK -2%, NBG -1.8%, RCL -1.2%, CCL -1.1%, AZN -1.1%, UBS -1.1%, LYG -0.8%, CS -0.8%

Other news: KOS -6.1% (announces secondary public offering of 15 mln common shares), BBEP -5.3% (announces public offering of 14 mln common units), END -5.3% (announced the appointment of a Chief Restructuring Officer), IBIO -4.7% (files for sale of up to 23,418,172 shares of common stock by Aspire Capital Fund), CNHI -4.3% (in sympathy with AGCO earnings), KCAP -3.8% (commences 3 mln share public offering), DYN -2.1% (launched 22.5 mln share common stock and 4 mln share mandatory convertible preferred stock offerings), NRP -2% (prices 8.5 mln common units at $12.02 per common unit), OTIV -1.6% (filed for $50 mln mixed securities shelf offering), BUD -1.6% (still checking), MBLY -1.4% (cont weakness), NUS -1% (following afternoon strength on volume)

Analyst comments: LVS -3.1% (downgraded to Hold from Buy at Deutsche Bank), URI -2.7% (downgraded to Neutral from Buy at BofA/Merrill), DE -2.6% (downgraded to Underperform from Neutral at BofA/Merrill), SAN -1.4% (downgraded to Reduce from Neutral at Nomura), CMI -1.3% (downgraded to Neutral from Buy at BofA/Merrill), ATI -1.2% (downgraded to Hold from Buy at KeyBanc Capital Mkts), USB -0.8% (downgraded to Mkt Perform from Strong Buy at Raymond James )

Оригинал статьи: gtstocks.com/analytics-07-10-2014.html
08.10.2014, 14:12
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY продолжает смотреть вниз

Ближайший уровень поддержки по SPY – 193.25 уровень сопротивления – 194.00



CAMP продажа от 20

SRTY смотрим на лонг

URI смотрим на продажу

EMES продажа ниже 95

TCS покупка от 16.50

Gapping up/down: COST +2% and YUM +1% after earnings, COTY +4% after upgrade; SAVE -3% and MON -2% after earnings/guidance, SAP -3% after reports of Job freeze, GPRO -2% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: COST +2.4%, YUM +1.3%

M&A news: TST +5% (to acquire BoardEx for ~$21 mln), SYMC +3.4% (may consider splitting up security and storage units, according to reports), AGN +1.9% (VRX and Pershing Square intend to increase bid for co), VRX +1.4% (co and Pershing Square intend to increase bid for Allergan (AGN)

Select financial related names showing strength: NBG +2%, ING +1.4%, SAN +1.4%, UBS +1.1%, HSBC +0.9%

Select metals/mining stocks trading higher: HL +3%, GFI +2.2%, AUY +1.6%, ABX +1.4%, IAG +1.3%, SLW +1.3%, GOLD +1.2%, SLV +1%, GDX +0.9%

Other news: GTAT +21.5% (seeing reports that co's first bankruptcy hearing has been scheduled for Thursday), SCOK +11.7% (issues update on construction and financing of underground Syngas Project), WYY +8.6% (receives 4 new federal contract awards; contract has period of performance of one year and total ~$2.7 mln), DRL +6.7% (disclosed the appointment of Nancy Reinhard as acting CFO), TST +5% (to acquire BoardEx for ~$21 mln), CMRX +4.9% (shows potential survival benefit in Adenovirus infection), PAH +3.7% (Pershing square disclosed a 26.1% active stake), TASR +3.7% (body camera momentum builds as adoption of AXON and EVIDENCE.com accelerates), OXGN +3% (announced first patient enrolled in Phase 1b/2 Study of Fosbretabulin combined with Pazopanib in patients with advanced recurrent ovarian cancer), MBLY +2.9% (ahead of TSLA event tomorrow), TKMR +2.5% (cont momentum/Ebola play), JCP +2.3% (ahead of anaylst day), ORAN +1.4% (in talks with other cos to create Netflix (NFLX) like streaming service, according to reports), BCRX +1.1% (present clinical trial results related to investigational drug RAPIVAB at the IDWeek Conference October 8-12)

Analyst comments: COTY +4.2% (upgraded to Neutral from Sell at B. Riley & Co), GLUU +2.3% (upgraded to Buy from Hold at The Benchmark Company), CMI +0.9% (initiated with a Buy at Stifel), LEAF +0.9% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: TILE -17.9%, (announces expansion of credit facility, planned bond redemption, share repurchase program ), SAVE -3.2%, (co sees Q3 adjusted operating margin in lower half of previous guidance range) MON -1.6%, RPM -1%, ASX -0.8%,.

Other news: RDY -4% (weak markets in India overnight), SAP -3.5% (reports suggesting job freeze until 2015 ), ICPT -3.2% (co decides not to present FLINT data at AASLD), RIO -2.1% (may still go after a defense deal with Anglo American (AAUKY), according to reports), INFY -1.5% (weak markets in India overnight), ALU -1.1% (still checking), GSK -0.8% (corruption allegations, according to reports out intraday), AZN -0.8% (may be in sympathy with GSK)

Analyst comments: SSNI -2.3% (downgraded to Neutral from Buy at Goldman), GPRO -2.2% (downgraded to Neutral from Overweight at Piper Jaffray), ARP -1.6% (initiated with a Mkt Perform at Raymond James)

Оригинал статьи: gtstocks.com/analytics-08-10-2014.html
09.10.2014, 13:58
Аватар для gtcapital
gtcapital gtcapital вне форума Интересующийся
Регистрация: 31.07.2014 / Сообщений: 40
Поблагодарили 0 раз(а) / Репутация: 1

По умолчанию SPY немного снижается на премаркете

Ближайший уровень поддержки по SPY – 196.00 уровень сопротивления – 197.25



Поздравляем всех с началом сезона отчетов. Вчера после закрытия рынка отчиталась положительно Alcoa Inc. Инвесторы могут положительно настроиться на рост рынка в ближайшие дни.

Alcoa — американская металлургическая фирма, 3-ий по величине производитель алюминия. Трехмесячный результат о деятельности данной фирмы, кой выходит 8 октября окажет мощное воздействие на цену акций.

GILD продажа от 109

AMGN продажа от 140

SSO продажа от 117

GOLD продажа ниже 70

URI покупка выше 103

DUST смотрим на лонг

Gapping up/down: RT +18% and AA +1.6% after earnings; AUXL +11% after merger ENDP, AGN +2.4% after upgrade; GPS -10% after guiding and CEO transition news, VOD -3% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance/SSS: RT +18.2%, DRWI +7.7%, EXAR +7.7%, LB +2.9%, AGN +2.4%, ZUMZ +1.8%, AA +1.6%, PEP +1.6%

M&A news: AUXL +10.7% (Endo (ENDP) to acquire Auxilium Pharmaceuticals in a cash and stock transaction for ~$2.6 bln, or $33.25 per share)

Select metals/mining stocks trading higher: PAAS +1.9%, SLV +1.6%, SSRI +1.2%, CDE +1.2%, AU +1%, HMY +0.9%, ABX +0.9%, GLD +0.7%, GDX +0.6%

Other news: SFXE +10.1% (announces that Chairman and CEO Robert F.X. Sillerman completed the purchase of 575k shares today), GTAT +10% (cont volatility), UAL +4.7% (reported September 2014 consolidated traffic decreased 0.2%, consolidated capacity decreased 0.4%), BLDP +4.4% (Ballard Power announces multi-year fuel cell supply agreement with Plug Power (PLUG) for forklift market), CGG +3.3% (reports vessel utilization and fleet allocation updates for third quarter 2014), NUAN +1.9% (rumors on Carl Icahn tweet — potential acquistion target), PLUG +1.3% (Ballard Power announces multi-year fuel cell supply agreement with Plug Power (PLUG) for forklift market), GNC +1.3% (positive mention on Wednesday's Mad Money)

Analyst comments: UAL +4.7% (added to Global Focus list at Credit Suisse), LPSN +2.6% (upgraded to Outperform from Neutral at Credit Suisse), AGN +2.4% (initiated with a Buy at Deutsche Bank), UTI +0.9% (upgraded to Outperform from Market Perform at Wells Fargo), TSLA +0.8% (ahead of D-day event, also added to Global Focus list at Credit Suisse), ROYT +0.8% (upgraded to Buy at Stifel), JCP +0.6% (Hearing defended at Piper Jaffray--reits Overweight rating), IIVI +0.6% (upgraded to Buy at DA Davidson)

Gapping down
In reaction to disappointing earnings/guidance: ARCW -18%, KFX -14.8%, GPS -9.7%, (also announces CEO transition news), EOPN -8.9%, DEST -1.4%,.

M&A news: ENDP -0.7% (Endo to acquire Auxilium Pharmaceuticals)

Select financial related names showing weakness: DB -3.2%, BCS -2.7%, SAN -2.7%, RBS -2%, HSBC -1.8%, LYG -1.4%

Select oil/gas related names showing early weakness: TOT -2.7%, RDS.A -2.4%, BP -1.4%, STO -1.3%, STO -1.3%, RIG -1%

Other news: PT -4.4% (still checking), ARWR -3.8% (higher following Deutsche Bank analyst appearance on CNBC defending the company, said today's sell off was over done), ONTX -3.2% (co filed for a $100 mln mixed securities shelf offering; co also filed for a 228,647 share common stock offering by selling shareholders), STV -2.2% (disclosed further update on its asset restructuring), X -0.8% (CAD $ 185 mln debtor financing facility approved, according to reports), TWTR -0.7% (Twitter's exec Vivian Schiller to leave the company with part of media consolidation, according to reports)

Analyst comments: HUB.B -5% (downgraded to Perform at Oppenheimer), ARWR -3.8% (downgraded to Sector Perform at RBC Capital Mkts), VOD -3.1% (downgraded to Reduce from Neutral at Nomura), ERIC -1.9% (reinstated with a Underperform at BofA/Merrill)

Оригинал статьи: gtstocks.com/analytics-09-10-2014.html
Ответить


Опции темы

Ваши права в разделе
Вы не можете создавать новые темы
Вы не можете отвечать в темах
Вы не можете прикреплять вложения
Вы не можете редактировать свои сообщения

BB коды Вкл.
Смайлы Вкл.
[IMG] код Вкл.
HTML код Выкл.
Trackbacks are Выкл.
Pingbacks are Выкл.
Refbacks are Выкл.



Текущее время: 02:23. Часовой пояс GMT.


Перевод: zCarot
Copyright ©2000 - 2017, Jelsoft Enterprises Ltd.
SEO by vBSEO